D
Recursion Pharmaceuticals, Inc. RXRX
$4.44 $0.122.73% NASDAQ
Recommendation
Prev Close
$4.32
Volume
5,245,665
Avg Vol (90D)
35,588,803
Market Cap
$2.25B
Dividend & Yield
--
52-Week Range
$3.79 - $12.36
P/E (TTM)
--
EPS (TTM)
-$1.81
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk
10/13/2025 - MarketBeat
ARK Investment Acquires 338K Shares of Recursion Pharmaceuticals (RXRX)
12/3/2025 - GuruFocus
Cathie Wood's ARK Investment buys 338K shares of Recursion Pharmaceuticals today
12/3/2025 - TipRanks Financial Blog
Cathie Wood's ARK Investment buys 338K shares of Recursion Pharmaceuticals today
12/3/2025 - The Fly
Recursion Pharmaceuticals (RXRX, $4.36) Aroon Indicator entered a Downtrend on December 01, 2025.
12/2/2025 - Tickeron - Stocks
Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025
12/1/2025 - Globe Newswire
Recursion Pharmaceuticals (RXRX): Valuation Insights Following New Partnerships and Better-Than-Expected Quarterly Results
12/1/2025 - Simply Wall St
Will Recursion (RXRX) Share Registration Deepen Its Tech Partnerships or Signal a Shift in Strategy?
11/29/2025 - Simply Wall St
Recursion Pharmaceuticals (RXRX, $4.63) Aroon Indicator entered a Downtrend on November 28, 2025.
11/29/2025 - Tickeron - Technical Analysis
Recursion Pharmaceuticals (RXRX, $4.63) entered Uptrend as Momentum indicator ascends above 0 level on Nov 28, 2025
11/29/2025 - Tickeron - Technical Analysis
XTX Topco Ltd Buys New Shares in Recursion Pharmaceuticals, Inc. $RXRX
11/27/2025 - MarketBeat
Recursion Pharmaceuticals (RXRX, $4.41) Aroon Indicator entered a Downtrend on November 26, 2025.
11/27/2025 - Tickeron - Technical Analysis
Recursion Pharmaceuticals (RXRX, $4.41) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 26, 2025
11/27/2025 - Tickeron - Technical Analysis
Rockefeller Capital Management L.P. Sells 170,691 Shares of Recursion Pharmaceuticals, Inc. $RXRX
11/27/2025 - MarketBeat
Recursion Pharmaceuticals (RXRX, $4.37) Aroon Indicator entered a Downtrend on November 25, 2025.
11/26/2025 - Tickeron - Stocks
Is the Market Bullish or Bearish on Recursion Pharmaceuticals Inc?
11/26/2025 - Benzinga
Recursion Pharmaceuticals (RXRX, $4.33) Aroon Indicator entered a Downtrend on November 24, 2025.
11/25/2025 - Tickeron - Stocks
Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?
11/24/2025 - Yahoo! Finance: News
Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?
11/24/2025 - Fool.com Headlines
ARK Invest Increases Stake in Recursion Pharmaceuticals (RXRX)
11/24/2025 - GuruFocus
Recursion Pharmaceuticals (RXRX): Evaluating Valuation After Fresh Leadership, Pharma Partnerships, and Market Optimism
11/24/2025 - Simply Wall St
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives Consensus Rating of "Hold" from Analysts
11/23/2025 - MarketBeat
Recursion Pharmaceuticals, Inc. $RXRX Shares Purchased by Kingsview Wealth Management LLC
11/23/2025 - MarketBeat
Top Biotech Stocks To Watch Today - November 21st
11/22/2025 - MarketBeat
These Are the Only 6 Stock Stocks in NVIDIA's 13F Portfolio
5/22/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$43.69M
EBITDA (TTM)
-$646.50M
EBIT (TTM)
-$723.67M
Net Income (TTM)
-$715.54M
Balance Sheet
Total Assets (Q)
$1.40B
Total Debt (Q)
$82.37M
Total Liabilities (Q)
$352.58M
Book Value Per Share (Q)
$2.13
Cash Flow
Cash from Operations (TTM)
-$441.17M
Cash from Investing (TTM)
$259.83M
Cash from Financing (TTM)
$400.17M
Net Change in Cash (TTM)
$231.31M
Filings
Filing Date
Wednesday, November 5, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Loading...
Beta
3.01
7-Day Total Return
6.24%
30-Day Total Return
-27.50%
60-Day Total Return
-5.74%
90-Day Total Return
-29.79%
Year to Date Total Return
-38.56%
1-Year Total Return
-37.52%
2-Year Total Return
-40.22%
3-Year Total Return
-51.37%
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $3.79
52-week High
Feb 18, 2025 - $12.36
Valuation
Market Cap
$2.25B - Mid Cap
Enterprise Value
$1.67B
Price/Sales (TTM)
44.22
Price/Book (Q)
2.03
Dividends and Shares
Shares Outstanding
446.99
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.recursion.com
Phone Number
385 269 0203
Address
41 South Rio Grande Street
Salt Lake City, UT 84101
Country
United States
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology... more
NASDAQ 12/03/2025 10:26AM Eastern Quotes delayed